pyruvaldehyde has been researched along with tetrodotoxin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babes, A; Bierhaus, A; Brownlee, M; Cooper, ME; Dehmer, T; Eberhardt, M; Edelstein, D; Elvert, R; Fleming, T; Forbes, J; Haberkorn, U; Humpert, PM; Kichko, TI; Konrade, I; Lasischka, F; Lasitschka, F; Leffler, A; Lukic, IK; Mier, W; Morcos, M; Nau, C; Nawroth, PP; Neacsu, C; Neuhuber, WL; Pirags, V; Rabbani, N; Reeh, PW; Sauer, SK; Schnölzer, M; Schwaninger, M; Stern, DM; Stoyanov, S; Thornalley, PJ; Ziegler, D | 1 |
1 other study(ies) available for pyruvaldehyde and tetrodotoxin
| Article | Year |
|---|---|
Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy.
Topics: Animals; Cerebrovascular Circulation; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Humans; Hyperalgesia; Mice; Mice, Inbred C57BL; NAV1.8 Voltage-Gated Sodium Channel; Neural Conduction; Nociceptors; Pyruvaldehyde; Sodium Channels; Streptozocin; Tetrodotoxin | 2012 |